|
PIGM expression based on
|
KIRP : Kidney renal papillary cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 4.857600E-03 |
|
KIRP : Kidney renal papillary cell carcinoma Note
Cancer stage information is not available for 89 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
9.003700E-04 |
| Normal-vs-Stage2 |
3.826000E-01 |
| Normal-vs-Stage3 |
5.107800E-01 |
| Normal-vs-Stage4 |
9.235800E-01 |
| Stage1-vs-Stage2 |
4.546600E-01 |
| Stage1-vs-Stage3 |
1.863040E-01 |
| Stage1-vs-Stage4 |
3.960400E-01 |
| Stage2-vs-Stage3 |
7.789200E-01 |
| Stage2-vs-Stage4 |
5.772600E-01 |
| Stage3-vs-Stage4 |
7.318000E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient race information is not available for 15 samples and two samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
2.562000E-03 |
| Normal-vs-AfricanAmerican |
6.116300E-02 |
| Normal-vs-Asian |
7.747900E-02 |
| Caucasian-vs-AfricanAmerican |
4.589200E-01 |
| Caucasian-vs-Asian |
8.193200E-01 |
| AfricanAmerican-vs-Asian |
6.014400E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
1.838010E-04 |
| Normal-vs-Female |
8.932000E-01 |
| Male-vs-Female |
4.639200E-04 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient BMI information is not available for 72 samples.
| Descriptions |
| Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
| Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Normal_Weight |
1.583790E-01 |
| Normal-vs-Extreme_Weight |
2.025300E-04 |
| Normal-vs-Obese |
1.015030E-01 |
| Normal-vs-Extreme_Obese |
8.087900E-02 |
| Normal_Weight-vs-Extreme_Weight |
1.213150E-01 |
| Normal_Weight-vs-Obese |
8.755600E-01 |
| Normal_Weight-vs-Extreme_Obese |
7.501200E-01 |
| Extreme_Weight-vs-Obese |
1.800490E-02 |
| Extreme_Weight-vs-Extreme_Obese |
3.745000E-01 |
| Obese-vs-Extreme_Obese |
6.966800E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient age information is not available for 3 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
3.275200E-01 |
| Normal-vs-Age(41-60Yrs) |
1.104200E-01 |
| Normal-vs-Age(61-80Yrs) |
1.407080E-04 |
| Normal-vs-Age(81-100Yrs) |
4.11639999999824E-05 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
4.828000E-02 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
1.366430E-02 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
1.982560E-03 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
1.138350E-02 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
9.162600E-03 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
5.433600E-02 |
|
|
KIRP : Kidney renal papillary cell carcinoma NOTE
Histology information is not available for 17 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-VS-Type1 PRCC |
1.224790E-03 |
| Normal-VS-Type2 PRCC |
5.080900E-03 |
| Normal-VS-KIRP CIMP |
9.428500E-02 |
| Normal-VS-Unclassified PRCC |
3.460400E-01 |
| Type1 PRCC-VS-Type2 PRCC |
6.893600E-01 |
| Type1 PRCC-VS-KIRP CIMP |
1.654320E-02 |
| Type1 PRCC-VS-Unclassified PRCC |
1.255440E-01 |
| Type2 PRCC-VS-KIRP CIMP |
1.336690E-03 |
| Type2 PRCC-VS-Unclassified PRCC |
1.660560E-01 |
| KIRP CIMP-VS-Unclassified PRCC |
1.230450E-02 |
|
Histologic PRCC subtypes: Ricketts CJ et al, The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma. Cell Rep. 2018 Apr 3;23(1):313-326.e5. doi: 10.1016/j.celrep.2018.03.075
|
KIRP : Kidney renal papillary cell carcinoma Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 211 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
3.564500E-04 |
| Normal-vs-N1 |
3.028200E-01 |
| Normal-vs-N2 |
4.764000E-01 |
| N0-vs-N1 |
9.360600E-03 |
| N0-vs-N2 |
7.491200E-01 |
| N1-vs-N2 |
3.328200E-01 |
|
|
